BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31143935)

  • 1. Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.
    Yang Y; Wu L; Shu XO; Cai Q; Shu X; Li B; Guo X; Ye F; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Brenner H; Chenevix-Trench G; Campa D; Castelao JE; Gago-Dominguez M; Dörk T; Hollestelle A; Lophatananon A; Muir K; Neuhausen SL; Olsson H; Sandler DP; Simard J; Kraft P; Pharoah PDP; Easton DF; Zheng W; Long J
    J Natl Cancer Inst; 2020 Mar; 112(3):295-304. PubMed ID: 31143935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.
    Yang Y; Wu L; Shu X; Lu Y; Shu XO; Cai Q; Beeghly-Fadiel A; Li B; Ye F; Berchuck A; Anton-Culver H; Banerjee S; Benitez J; Bjørge L; Brenton JD; Butzow R; Campbell IG; Chang-Claude J; Chen K; Cook LS; Cramer DW; deFazio A; Dennis J; Doherty JA; Dörk T; Eccles DM; Edwards DV; Fasching PA; Fortner RT; Gayther SA; Giles GG; Glasspool RM; Goode EL; Goodman MT; Gronwald J; Harris HR; Heitz F; Hildebrandt MA; Høgdall E; Høgdall CK; Huntsman DG; Kar SP; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Koushik A; Lambrechts D; Le ND; Levine DA; Massuger LF; Matsuo K; May T; McNeish IA; Menon U; Modugno F; Monteiro AN; Moorman PG; Moysich KB; Ness RB; Nevanlinna H; Olsson H; Onland-Moret NC; Park SK; Paul J; Pearce CL; Pejovic T; Phelan CM; Pike MC; Ramus SJ; Riboli E; Rodriguez-Antona C; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Shan K; Siddiqui N; Sieh W; Stampfer MJ; Sutphen R; Swerdlow AJ; Szafron LM; Teo SH; Tworoger SS; Tyrer JP; Webb PM; Wentzensen N; White E; Willett WC; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
    Cancer Res; 2019 Feb; 79(3):505-517. PubMed ID: 30559148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
    Zhao X; Yang M; Fan J; Wang M; Wang Y; Qin N; Zhu M; Jiang Y; Gorlova OY; Gorlov IP; Albanes D; Lam S; Tardón A; Chen C; Goodman GE; Bojesen SE; Landi MT; Johansson M; Risch A; Wichmann HE; Bickeböller H; Christiani DC; Rennert G; Arnold SM; Brennan P; Field JK; Shete S; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Woll PJ; Lazarus P; Schabath MB; Aldrich MC; Patel AV; Davies MPA; Ma H; Jin G; Hu Z; Amos CI; Shen H; Dai J
    Cancer; 2024 Mar; 130(6):913-926. PubMed ID: 38055287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.
    Song MA; Brasky TM; Marian C; Weng DY; Taslim C; Dumitrescu RG; Llanos AA; Freudenheim JL; Shields PG
    Epigenetics; 2015; 10(12):1177-87. PubMed ID: 26680018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
    Xu Z; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk.
    Zhu J; Yang Y; Kisiel JB; Mahoney DW; Michaud DS; Guo X; Taylor WR; Shu XO; Shu X; Liu D; Li B; Tao R; Cai Q; Zheng W; Long J; Wu L
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2079-2087. PubMed ID: 34497089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D, DNA methylation, and breast cancer.
    O'Brien KM; Sandler DP; Xu Z; Kinyamu HK; Taylor JA; Weinberg CR
    Breast Cancer Res; 2018 Jul; 20(1):70. PubMed ID: 29996894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
    Liu X; Peng Y; Wang J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
    Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
    Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
    de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
    BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.
    Guo Y; Warren Andersen S; Shu XO; Michailidou K; Bolla MK; Wang Q; Garcia-Closas M; Milne RL; Schmidt MK; Chang-Claude J; Dunning A; Bojesen SE; Ahsan H; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bogdanova NV; Bonanni B; Børresen-Dale AL; Brand J; Brauch H; Brenner H; Brüning T; Burwinkel B; Casey G; Chenevix-Trench G; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Dumont M; Fasching PA; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Fostira F; Gammon M; Giles GG; Guénel P; Haiman CA; Hamann U; Hooning MJ; Hopper JL; Jakubowska A; Jasmine F; Jenkins M; John EM; Johnson N; Jones ME; Kabisch M; Kibriya M; Knight JA; Koppert LB; Kosma VM; Kristensen V; Le Marchand L; Lee E; Li J; Lindblom A; Luben R; Lubinski J; Malone KE; Mannermaa A; Margolin S; Marme F; McLean C; Meijers-Heijboer H; Meindl A; Neuhausen SL; Nevanlinna H; Neven P; Olson JE; Perez JI; Perkins B; Peterlongo P; Phillips KA; Pylkäs K; Rudolph A; Santella R; Sawyer EJ; Schmutzler RK; Seynaeve C; Shah M; Shrubsole MJ; Southey MC; Swerdlow AJ; Toland AE; Tomlinson I; Torres D; Truong T; Ursin G; Van Der Luijt RB; Verhoef S; Whittemore AS; Winqvist R; Zhao H; Zhao S; Hall P; Simard J; Kraft P; Pharoah P; Hunter D; Easton DF; Zheng W
    PLoS Med; 2016 Aug; 13(8):e1002105. PubMed ID: 27551723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
    Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort.
    Wilson LE; Harlid S; Xu Z; Sandler DP; Taylor JA
    Int J Obes (Lond); 2017 Jan; 41(1):194-199. PubMed ID: 27773939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.
    Sathyanarayanan A; Tanha HM; Mehta D; Nyholt DR
    Commun Biol; 2022 Jun; 5(1):594. PubMed ID: 35710732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.
    Zheng W; Wen W; Gao YT; Shyr Y; Zheng Y; Long J; Li G; Li C; Gu K; Cai Q; Shu XO; Lu W
    J Natl Cancer Inst; 2010 Jul; 102(13):972-81. PubMed ID: 20484103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients.
    Lee NY; Hum M; Tan GP; Seah AC; Ong PY; Kin PT; Lim CW; Samol J; Tan NC; Law HY; Tan MH; Lee SC; Ang P; Lee ASG
    Clin Epigenetics; 2024 May; 16(1):66. PubMed ID: 38750495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenome-wide association study of breast cancer using prospectively collected sister study samples.
    Xu Z; Bolick SC; DeRoo LA; Weinberg CR; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2013 May; 105(10):694-700. PubMed ID: 23578854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heritable DNA methylation marks associated with susceptibility to breast cancer.
    Joo JE; Dowty JG; Milne RL; Wong EM; Dugué PA; English D; Hopper JL; Goldgar DE; Giles GG; Southey MC;
    Nat Commun; 2018 Feb; 9(1):867. PubMed ID: 29491469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose.
    Chung RH; Chiu YF; Wang WC; Hwu CM; Hung YJ; Lee IT; Chuang LM; Quertermous T; Rotter JI; Chen YI; Chang IS; Hsiung CA
    Diabetologia; 2021 Jul; 64(7):1613-1625. PubMed ID: 33842983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.